Genizon BioSciences and the 2,600 Genomes of Quebec’s Founders
Genizon BioSciences, a private firm in Quebec with about 135 employees, has been awarded $31 million from the Dutch venture capital firm Biotechnology Turnaround Fund to uncover associations between genes and diseases such as obesity, diabetes, and Alzheimer’s.
There are a number of companies concentrating on the correlation between genetics and disease, but the reason that Genizon BioSciences stood out to me is the source of the DNA that the company studies. Genizon uses DNA from descendants of the Quebec Founder Population. This population began with roughly 2,600 individuals who settled Quebec between 1608 and 1760 (although more than 15,000 French had immigrated to Quebec in this period, the vast majority continued to travel westward across Canada) and is estimated to be over 6 million people today. Genizon uses this unique population for a number of beneficial reasons, including:
- There has been very little intermarriage with English populations, resulting in minimal gene dilution – an estimated 68% of the gene pool is derived from the 2,600 founders!
- Fewer variations for known diseases, making existing variations easier to find;
- The large population makes recruiting easier.
- And according to the website: “The Projet BALSAC and the Université de Montréal’s Programme de recherche en démographie historique comprehensively document the genealogy of the vast majority of the Quebec Founder Population from founding to modern times. Access to these databases supports the gene discovery process.”
I was particularly interested in this population because I happen to a descendant of a number of Quebec founders through my paternal grandfather (whose Y-DNA is currently being analyzed by DNA Ancestry – I’ll be sure to share these results when I get them back). Individuals can volunteer to be part of the project, but all four of their grandparents must be French Canadian from Quebec.
Genizon has already had success in this field of study, previously discovering multiple genes that are associated with Crohn’s disease (See Genome-wide association study for Crohn’s disease in the Quebec Founder Population identifies multiple validated disease loci (pdf)).
For More Information:


January 14th, 2008 at 2:07 pm
the genetics of autism, a list of several upcoming events and conferences, and references blog entries from Brandon Keim at Wired Science, Jacob Goldstein at The Wall Street Journal Health Blog, Myles Axton of Free Association, and Blaine Bettinger ofThe Genetic Genealogist. To received PredictER News Brief as an email newsletter send an email to listserv@listserv.iupui.edu with “subscribe PREDICTER-L” in the message body. – J.O.
January 12th, 2008 at 10:17 am
[...] Your page is on StumbleUpon [...]
January 14th, 2008 at 9:58 am
[...] means for them. Genizon BioSciences and the 2,600 Genomes of Quebec’s Founders. Blaine Bettinger, The Genetic Genealogist. 9 January 2008. Genizon BioSciences, a private firm in Quebec with about 135 employees, has been [...]
February 11th, 2008 at 3:02 am
[...] BioSciences will examine genetic diseases using DNA from descendants of the Quebec Founder [...]
April 29th, 2008 at 12:50 pm
[...] of … http://www.medicalnewstoday.com/articles/96854.php • Found on Yahoo! Search Genizon BioSciences and the 2,600 Genomes of Quebec’s Founders " The Genetic Genea… Genizon BioSciences, a private firm in Quebec with about 135 employees, has been awarded $31 [...]
March 29th, 2009 at 1:14 pm
Nice, thumbs up
John’s last blog post..How is Crohn’s disease different from ulcerative colitis?
August 8th, 2009 at 2:31 am
It should be searching project. Congrats. BTW thanks for “I Have The Results of My Genetic Genealogy Test, Now What?” named e-book.